Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chavance

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Revue D'Epidemiologie Et De Sante Publique|February 16, 2000
[Use of GEE for modeling censored correlated data: application to the study of risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis]J Bloch, M Chavance, J Lellouch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV/HTLV-I coinfection and clinical grade at diagnosisM Chavance, C Neisson-Vernant, D Quist, et al.
Human Nutrition. Clinical Nutrition|September 1, 1986
Thyroxine-binding prealbumin, overnutrition and apolipoprotein A1M Chavance, C Labarre, F Bleiberg, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie|September 1, 1984
[Detection of specific antibodies for HTLV in French blood donors]L Schaffar-Deshayes, A M Couroucé, N Monplaisir, et al.
Journal of Clinical Epidemiology|March 10, 2007
Relative-risk ratio was a useful measure of differential association in cohort and case-series studiesM N Hocine, P Tubert-Bitter, T Moreau, et al.
Neuroepidemiology|January 12, 2007
Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?V Petiot, C Quantin, G Le Teuff, et al.
European Journal of Epidemiology|March 1, 1991
HTLV-I infection in French West Indies: a case-control studyN Frery, M Chavance, I Valette, et al.
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
International Journal of Cancer|November 15, 1984
Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West IndiesL Schaffar-Deshayes, M Chavance, N Monplaisir, et al.
Neuropsychologia|January 1, 1990
Handedness, immune disorders and information biasM Chavance, G Dellatolas, M G Bousser, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Revue D'Epidemiologie Et De Sante Publique|February 16, 2000
[Use of GEE for modeling censored correlated data: application to the study of risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis]J Bloch, M Chavance, J Lellouch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV/HTLV-I coinfection and clinical grade at diagnosisM Chavance, C Neisson-Vernant, D Quist, et al.
Human Nutrition. Clinical Nutrition|September 1, 1986
Thyroxine-binding prealbumin, overnutrition and apolipoprotein A1M Chavance, C Labarre, F Bleiberg, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie|September 1, 1984
[Detection of specific antibodies for HTLV in French blood donors]L Schaffar-Deshayes, A M Couroucé, N Monplaisir, et al.
Journal of Clinical Epidemiology|March 10, 2007
Relative-risk ratio was a useful measure of differential association in cohort and case-series studiesM N Hocine, P Tubert-Bitter, T Moreau, et al.
Neuroepidemiology|January 12, 2007
Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?V Petiot, C Quantin, G Le Teuff, et al.
European Journal of Epidemiology|March 1, 1991
HTLV-I infection in French West Indies: a case-control studyN Frery, M Chavance, I Valette, et al.
International Journal of Epidemiology|December 5, 1998
Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.
International Journal of Cancer|November 15, 1984
Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West IndiesL Schaffar-Deshayes, M Chavance, N Monplaisir, et al.
Neuropsychologia|January 1, 1990
Handedness, immune disorders and information biasM Chavance, G Dellatolas, M G Bousser, et al.
Pageof 6